| Date Filed | Type | Description |
| 05/30/2023 |
4
| OBOYLE KEVIN C (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 6,754 shares
@ $0 |
|
| 06/13/2022 |
4
| OBOYLE KEVIN C (Director) has filed a Form 4 on Sientra, Inc.|
Txns:
| Granted 103,306 shares
@ $0 |
|
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2021 |
4
| OBOYLE KEVIN C (Director) has filed a Form 4 on Sientra, Inc.|
Txns:
| Granted 16,870 shares
@ $0 |
|
| 05/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/13/2020 |
4
| OBOYLE KEVIN C (Director) has filed a Form 4 on Wright Medical Group N.V.|
Txns:
| Unknown transaction of 16,306 shares
@ $30.75, valued at
$501.4k
Disposed/sold 11,691 options to buy
@ $27.84, valued at
$325.5k
Disposed/sold 9,907 options to buy
@ $24.49, valued at
$242.6k
Disposed/sold 10,275 options to buy
@ $27.86, valued at
$286.3k
Disposed/sold 11,765 options to buy
@ $21.24, valued at
$249.9k
Disposed/sold 11,018 options to buy
@ $20.62, valued at
$227.2k
Disposed/sold 6,034 options to buy
@ $21.66, valued at
$130.7k
Disposed/sold 7,538 options to buy
@ $19.45, valued at
$146.6k
Disposed/sold 6,448 options to buy
@ $18.04, valued at
$116.3k
Disposed/sold 7,800 options to buy
@ $25.2, valued at
$196.6k
|
|
| 06/09/2020 |
4
| OBOYLE KEVIN C (Director) has filed a Form 4 on Sientra, Inc.|
Txns:
| Granted 27,717 shares
@ $0 |
|
| 06/02/2020 |
4
| OBOYLE KEVIN C (Director) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Granted 17,998 shares
@ $0 |
|
| 05/26/2020 |
4
| OBOYLE KEVIN C (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 1,376 shares
@ $0 |
|
| 03/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2019 |
4
| OBOYLE KEVIN C (Director) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Sold 2,200 shares
@ $6.51, valued at
$14.3k
Sold 16,150 shares
@ $6.51, valued at
$105.1k
Paid exercise price by delivering 23,365 shares
@ $6.42, valued at
$150k
Paid exercise price by delivering 16,870 shares
@ $6.42, valued at
$108.3k
Exercised 25,000 options to buy
@ $6, valued at
$150k
Exercised 18,050 options to buy
@ $6, valued at
$108.3k
|
|
| 07/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2019 |
4
| OBOYLE KEVIN C (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Bought 1,675 shares
@ $60, valued at
$100.5k
|
|
| 06/04/2019 |
4
| OBOYLE KEVIN C (Director) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Granted 19,851 shares
@ $0 |
|
| 05/22/2019 |
4
| OBOYLE KEVIN C (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 6,049 shares
@ $0 |
|
| 03/21/2019 |
4
| OBOYLE KEVIN C (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 651 shares
@ $0 |
|
| 03/21/2019 |
3
| OBOYLE KEVIN C (Director) has filed a Form 3 on NEVRO CORP |
| 03/05/2019 |
4
| OBOYLE KEVIN C (Director) has filed a Form 4 on Wright Medical Group N.V.|
Txns:
| Sold 6,417 shares
@ $32, valued at
$205.3k
|
|
| 02/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2018 |
4
| OBOYLE KEVIN C (Director) has filed a Form 4 on Wright Medical Group N.V.|
Txns:
| Granted 3,804 shares
@ $0
Paid exercise price by delivering 626 shares
@ $24.83, valued at
$15.5k
Granted 9,907 options to buy
@ $24.49, valued at
$242.6k
|
|
| 06/07/2018 |
4
| OBOYLE KEVIN C (Director) has filed a Form 4 on Sientra, Inc.|
Txns:
| Granted 6,116 shares
@ $20.44, valued at
$125k
|
|
| 05/29/2018 |
4
| OBOYLE KEVIN C (Director) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Granted 18,866 shares
@ $0 |
|
| 05/09/2018 |
4
| OBOYLE KEVIN C (Director) has filed a Form 4 on Sientra, Inc.|
Txns:
| Bought 7,407 shares
@ $13.5, valued at
$100k
|
|
| 07/26/2017 |
4
| OBOYLE KEVIN C (Director) has filed a Form 4 on Wright Medical Group N.V.|
Txns:
| Granted 3,586 shares
@ $0
Granted 10,275 options to buy
@ $27.86, valued at
$286.3k
|
|
| 07/21/2017 |
4
| OBOYLE KEVIN C (Director) has filed a Form 4 on Wright Medical Group N.V.|
Txns:
| Paid exercise price by delivering 1,428 shares
@ $27.58, valued at
$39.4k
|
|
| 06/26/2017 |
4
| OBOYLE KEVIN C (Director) has filed a Form 4 on Sientra, Inc.|
Txns:
| Granted 12,861 shares
@ $9.72, valued at
$125k
|
|
| 05/30/2017 |
4
| OBOYLE KEVIN C (Director) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Granted 7,832 shares
@ $0 |
|
|